Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 505-514

  Szaumkessel, Marcin ^a,b   Richter, Julia ^a   Giefing, Maciej ^a,b   Jarmuz, Malgorzata ^b   Kiwerska, Katarzyna ^b   Tönnies, Holger ^a   Grenman, Reidar ^d   Heidemann, Simone ^a   Szyfter, Krzysztof ^b,c   Siebert, Reiner ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b INSTITUTE OF HUMAN GENETICS   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

DNA methylation; DNA repair; Fanconi anemia; Head and neck squamous cell carcinoma; Laryngeal cancer; Pyrosequencing

Indexed keywords

FANCONI ANEMIA PROTEIN;

ARTICLE; BRCA GENE; CANCER GENETICS; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; FEMALE; GENE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SQUAMOUS CELL CARCINOMA;

CELL LINE, TUMOR; DNA METHYLATION; EPIGENOMICS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; NEOPLASMS, SQUAMOUS CELL; PROMOTER REGIONS, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 79960004439     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1039     Document Type: Article

References (44)

1. Basu R, Mandai S, Ghosh A and Poddar TK: Role of tobacco in the development of head and neck squamous cell carcinoma in an eastern Indian population. Asian Pac J Cancer Prev 9: 381-386, 2008.
2. Psyrri A and DiMaio D: Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol 5: 24-31, 2008. (Pubitemid 351512426)
3. Goldenberg D, Golz A, Netzer A, et al: Epstein-Barr virus and cancers of the head and neck. Am J Otolaryngol 22: 197-205, 2001. (Pubitemid 32436187)
4. Alvarez Marcos CA, Llorente Pendas JL, Franco Gutierrez V, et al: Tumour recurrence in squamous head and neck cancer. Acta Otorrinolaringol Esp 58: 156-163, 2007 (In Spanish). (Pubitemid 47251043)
5. Specenier PM and Vermorken JB: Recurrent head and neck cancer: current treatment and future prospects. Expert Rev Anticancer Ther 8: 375-391, 2008. (Pubitemid 351836286)
6. Auerbach AD: Fanconi anemia and its diagnosis. Mutat Res 668: 4-10, 2009.
7. Tischkowitz MD and Hodgson SV: Fanconi anaemia. J Med Genet 40: 1-10, 2003. (Pubitemid 36115118)
8. Rego MA, Rolling FWIV and Howlett NG: The Fanconi anemia protein interaction network: casting a wide net. Mutat Res 668: 27-41, 2009.
9. Joenje H and Arwert F: Connecting Fanconi anemia to BRCA1. Nat Med 7: 406-407, 2001. (Pubitemid 32298534)
10. Zdzienicka MZ and Arwert F: Breast cancer and Fanconi anemia: what are the connections? Trends Mol Med 8: 458-460, 2002.
11. Alter BP: Fanconi's anemia and malignancies. Am J Hematol 53: 99-110, 1996.
12. Alter BP, Joenje H, Oostra AB and Pals G: Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg 131: 635-639, 2005. (Pubitemid 41058056)
13. Kutler DI, Auerbach AD, Satagopan J, et al: High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 129: 106-112, 2003. (Pubitemid 36070885)
14. Lustig JP, Lugassy G, Neder A and Sigler E: Head and neck carcinoma in Fanconi's anaemia - report of a case and review of the literature. Eur J Cancer B Oral Oncol 31B: 68-72, 1995.
15. Rosenberg PS, Socie G, Alter BP and Gluckman E Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105: 67-73, 2005 (Pubitemid 40053065)
16. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440, 2002.
17. Guida M, Sanguedolce F, Bufo P, et al: Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/pl6 genes in benign, premalignant and malignant endometrial lesions. Eur J Gynaecol Oncol 30: 267-270, 2009.
18. Amara K, Trimeche M, Ziadi S, Laatiri A, Hachana M and Korbi S: Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. Ann Oncol 19: 1774-1786, 2008.
19. Rosas SL, Koch W, Da Costa Carvalho MG, et al: Promoter hypermethylation patterns of p16, 06-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61: 939-942, 2001. (Pubitemid 32174408)
20. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M and Kelsey KT: Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21: 4231-4236, 2002. (Pubitemid 34753829)
21. Viswanathan M, Tsuchida N and Shanmugam G: Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105: 41-46, 2003. (Pubitemid 36418483)
22. Shaw RJ, Liloglou T, Rogers SN, et al: Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94: 561-568, 2006. (Pubitemid 43289761)
23. Taioli E, Ragin C, Wang XH, et al: Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer 9: 354, 2009.
24. Tischkowitz M and Dokal I: Fanconi anaemia and leukaemia - clinical and molecular aspects. Br J Haematol 126: 176-191, 2004. (Pubitemid 38961936)
25. Hirsch B, Shimamura A, Moreau L, et al: Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103: 2554-2559, 2004. (Pubitemid 38393006)
26. Wu Y, Shin-ya K and Brosh RM Jr: FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 28: 4116-4128, 2008. (Pubitemid 351812995)
27. Pejovic T, Yates JE, Liu HY, et al: Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res 66: 9017-9025, 2006. (Pubitemid 44521120)
28. Neveling K, Kalb R, Florl AR, et al: Disruption of the FA/BRCA pathway in bladder cancer. Cytogenet Genome Res 118: 166-176, 2007. (Pubitemid 350125253)
29. Narayan G, Arias-Pulido H, Nandula SV, et al: Promoter hypermethylation of FANCF: disruption of Fanconi anemia-BRCA pathway in cervical cancer. Cancer Res 64: 2994-2997, 2004. (Pubitemid 38581394)
30. Cheng NC, van de Vrugt H,J van der Valk MA, et al: Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet 9: 1805-1811, 2000.
31. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M and Kelsey KT: Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 23: 1000-1004, 2004. (Pubitemid 38250946)
32. Wreesmann VB, Estilo C, Eisele DW, Singh B and Wang SJ: Down-regulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69: 218-225, 2007. (Pubitemid 46934196)
33. Smith IM, Mithani SK, Mydlarz WK, Chang SS and Califano JA: Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers. ORL J Otorhinolaryngol Relat Spec 72: 44-50, 2010.
34. Gasco M, Sullivan A, Smith P, Farrell P, Numico G, Colantonio I, Merlano M and Crook T: Transcriptional silencing of Fanconi anaemia genes and clinical outcome in head and neck cancer. J Clin Oncol 22: 9546, 2004.
35. Jarmuz M, Golusinski W, Grenman R and Szyfter K: Analysis of chromosome aberrations in cell lines derived from laryngeal cancer in relation to tumor progression. Eur Arch Otorhinolaryngol 259: 269-273, 2002. (Pubitemid 34591725)
36. Jarvinen AK, Autio R, Haapa-Paananen S, et al: Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25: 6997-7008, 2006. (Pubitemid 44684840)
37. D'Andrea AD: The Fanconi road to cancer. Genes Dev 17: 1933-1936, 2003.
38. Lyakhovich A and Surralles J: Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer. Cancer Lett 232: 99-106, 2006. (Pubitemid 43053937)
39. Bauer VL, Braselmann H, Henke M, et al: Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med 86: 1353-1365, 2008.
40. Jing F, Zhang J, Tao J, et al: Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients. Onkologie 30: 14-19, 2007. (Pubitemid 46175615)
41. Balch C, Fang F, Matei DE, Huang TH and Nephew KP: Minireview: epigenetic changes in ovarian cancer. Endocrinology 150: 4003-4011, 2009.
42. Lee MN, Tseng RC, Hsu HS, et al: Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer. Clin Cancer Res 13: 832-838, 2007.
43. Derks S, Lentjes MH, Hellebrekers DM, De Bruine AP, Herman JG and van Engeland M: Methylation-specific PCR unraveled. Cell Oncol 26: 291-299, 2004. (Pubitemid 40916730)
44. Colella S, Shen L, Baggerly KA, Issa JP and Krahe R: Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150, 2003. (Pubitemid 36828724)